Ann: Quarterly Activities Report, page-63

My apologies if this has already been said, but it may be important to note the Peter Wall factor.

The man is the chairman of Phytotech Medical, the first Australian medical marijuana company, whose IPO earlier on in the week of 20c per share just closed today off at 74c. He's the guy who engineered the deal, and so is very much in the financial limelight at present:

http://www.copyright link/p/busines...nzy_over_asx_marijuana_eCGLmWl4uUEQiu5ppDZUML

As we have a pending acquisition looming, it would have to be the perfect timing to close the deal, considering Mr Phytotech is at the DUO acquisition helm.